Videos
Treating Cognitive Deficits in MS With Transcranial Direct Current Stimulation: Leigh Charvet, PhD
March 2nd 2022The professor of neurology at the NYU Grossman School of Medicine discussed her presentation at ACTRIMS Forum 2022, which showed better cognitive outcomes in MS following treatment with tDCS. [WATCH TIME: 3 minutes]
Discussing Epstein-Barr Virus and Multiple Sclerosis: Bruce Bebo, PhD
March 1st 2022The executive vice president of the National MS Society spoke on recently published data suggesting the relationship between EBV and MS, also sharing his opinion on the potential of vaccines. [WATCH TIME: 2 minutes]
Ganaxolone’s Significant Effect on CDKL5 Deficiency Disorder: Elia Pestana-Knight, MD
March 1st 2022The pediatric epileptologist at Cleveland Clinic provided insight on her presentation at the 2022 AAN Annual Meeting that evaluated ganaxolone in phase 3 study of patients with CDKL5 deficiency disorder. [WATCH TIME: 4 minutes]
Raising Awareness for Rare Diseases, Myasthenia Gravis: Hong Sun, MD, PhD
February 28th 2022The global compound development team leader at Janssen discussed the importance of Rare Disease Day and one in particular, myasthenia gravis, which affects approximately 36,000 to 60,000 people in the US. [WATCH TIME: 3 minutes]
ACTRIMS Forum Takeaways and Unmet Needs in Multiple Sclerosis: Bruce Bebo, PhD
February 27th 2022The executive vice president of the National MS Society spoke on the primary theme of ‘biomarkers’ at this year’s meeting, as well as the areas he believes require the most attention for patients with MS. [WATCH TIME: 3 minutes]
Cost Efficiency and Promoting Healthy Lifestyles in Multiple Sclerosis: Bruce Bebo, PhD
February 25th 2022At the ACTRIMS Forum 2022, the executive vice president of the National MS Society commented on the need to diagnose and initiate treatment for MS early, as well as employing wellness strategies to reduce risk of comorbidities. [WATCH TIME: 4 minutes]
Discussing Economic Burden for Patients With Multiple Sclerosis: Bruce Bebo, PhD
February 24th 2022The executive vice president of the National MS Society spoke on the updated data from an analysis on economic burden, which illustrated the ‘staggering’ impact of the disease. [WATCH TIME: 4 minutes]
Gearing Up For the 2022 ACTRIMS Forum: Jeffrey Cohen, MD
February 24th 2022The professor of neurology at Cleveland Clinic and president of ACTRIMS noted his excitement for this year’s Forum, which will feature presentations on a variety of topics in the field of multiple sclerosis. [WATCH TIME: 2 minutes]
Discussing Findings From the ILAE Task Force on Stigma in Epilepsy: Joan K. Austin, PhD, RN, FAAN
February 23rd 2022The Distinguished Professor Emerita at Indiana University School of Nursing spoke on what the task force discovered in a review of literature on stigma from 1985 through 2019. [WATCH TIME: 7 minutes]
Raising Awareness of Neuropsychiatric Symptoms in Neurodegenerative Diseases: George Grossberg, MD
February 23rd 2022The director of Geriatric Psychiatry at the St Louis University School of Medicine discussed the need to improve awareness of the signs of psychiatric-related symptoms and to eliminate the stigmas associated with them. [WATCH TIME: 3 minutes]
The Need to Understand and Tackle Stigma in Epilepsy: Joan K. Austin, PhD, RN, FAAN
February 22nd 2022The Distinguished Professor Emerita at Indiana University School of Nursing spoke on the prevalence of stigma in the field of epilepsy and how it can affect the daily life of patients. [WATCH TIME: 4 minutes]
Epstein-Barr Virus and MS: Exploring Implications From Bench to Bedside
February 21st 2022Alberto Ascherio, MD, DrPH, and Lawrence Steinman, MD, join NeurologyLive in a conversation about the clinical and research implications of a causative relationship between Epstein-Barr virus and multiple sclerosis.
Takeaways, Highlights From the Institutional Perspectives in Neurology: MS: Eric Klawiter, MD, MSc
February 18th 2022The director of the Multiple Sclerosis and Neuromyelitis Optica Unit at Massachusetts General Hospital commented on presentations given at the recent event, as well as key takeaways from his own discussion on novel imaging approaches in multiple sclerosis. [WATCH TIME: 2 minutes]
Discussing Novel Imaging Outcomes in Multiple Sclerosis: Eric Klawiter, MD, MSc
February 17th 2022The director of the Multiple Sclerosis and Neuromyelitis Optica Unit at Massachusetts General Hospital outlined a presentation he gave at a recent Institutional Perspectives in Neurology: MS event. [WATCH TIME: 3 minutes]
Next Steps for ATA188, Research Related to EBV and Multiple Sclerosis: AJ Joshi, MD
February 17th 2022The chief medical officer at Atara Biotherapeutics provided insight on the future direction of its investigational agent ATA188 following new data that suggested a link between Epstein-Barr virus and multiple sclerosis. [WATCH TIME: 4 minutes]
Capabilities of Allegheny Health Network’s Expansive Headache Registry: Andrea Synowiec, DO
February 16th 2022The assistant director of the Allegheny Headache Center explained the origins of the recently launched headache registry, which keeps data about patients’ responses to medications. [WATCH TIME: 6 minutes]
Understanding Differences in B-Cell Depleting Medications for MS: Kristin Galetta, MD, MSEd
February 15th 2022The professor of neurology at Brigham and Women’s Hospital discussed her presentation on B-cell depleting therapies such as ocrelizumab and ofatumumab for the treatment of multiple sclerosis. [WATCH TIME: 2 minutes]
